Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 2, 1998, Pages 87-97

  Furusawa, Shinobu ^a   Wu, Jianghong ^a   Fujimura, Tsutomu ^b   Nakano, Shinya ^a   Nemoto, Satoko ^a   Takayanagi, Motoaki ^a   Sasaki, Ken Ichi ^a   Takayanagi, Yoshio ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis inducing effect; Cepharanthine; DNA ladder; Fas; LDH release; P388 cells; Reactive oxygen species

Indexed keywords

ALKALOID DERIVATIVE; CEPHARANTHINE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; DRUG ISOLATION; MOUSE; NONHUMAN;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL DIVISION; DOXORUBICIN; L-LACTATE DEHYDROGENASE; LEUKEMIA P388; MICE; REACTIVE OXYGEN SPECIES; TUMOR CELLS, CULTURED;

EID: 0031944325     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1998.20.2.485636     Document Type: Article

References (37)

1. Gerschenson, L.E., Rotello, R.J. Apoptosis: A different type of cell death. FASEB J 1992, 6: 2450-5.
2. Arends, M.J., Morris, R.G., Wyllie, A.H. Apoptosis: The role of the endonuclease. Am J Pathol 1990, 136: 593-608.
3. Miura, M., Zhu, H., Rotello, R., Hartwieg, E.A., Yuan, J. Induction of apoptosis in fibroblasts by IL-1§-converting enzyme, a mammalian homology of the C. elegans cell death gene ced-3. Cell 1993, 75: 653-60.
4. Martin, S.J., Green, D.R. Protease activation during apoptosis: Death by a thousand cuts? Cell 1995, 82: 349-52.
5. Cai, Z., Stancou, R., Korner, M., Chouaib, S. Impairment of Fas-antigen expression in adriamycin-resistant but not TNF-resistant MCF7 tumor cells. Int J Cancer 1996, 68: 535-46.
6. Basolo, F., Pollina, L., Fontanini, G., Fiore, L., Pacini, F., Baldanz, A. Apoptosis and proliferation in thyroid carcinoma: Correlation with bcl-2 and p53 protein expression. Br J Cancer 1997, 75: 537-41.
7. Kennedy, M.M., Lamb, D., King, G., Kerr, K.M. Cell proliferation, cell loss and expression of bcl-2 and p53 in human pulmonary neoplasma. Br J Cancer 1997, 75: 545-7.
8. Hampton, M.B., Orrenius, S. Dual regulation of caspase activity by hydrogen peroxide: Implications for apoptosis. FEBS Letters 1997, 414: 552-6.
9. Miyahara, M., Aono, K., Shimono, J.S., Baba, K., Yamashita, S. Protection by cepharanthin of the mitochondrial function from damage induced by snake venom phospholipase A2. Cell Struct Fund 1978, 3: 61-5.
10. Kato, T. Suzumura, Y. Potentiation of antitumor activity of vincristine by the biscoclaurine alkaloid cepharanthin. J Natl Cancer Inst 1987, 79: 527-32.
11. Gao, X.-S., Asaumi, J., Kawasaki, S. et al. Effect of cepharanthin and hyperthermia on the intracellular accumulation of adriamycin in the NIH3T3 cell fines transfected with oncogenes accompanied with pSV2neo Vector. Anticancer Res 1995, 15: 1991-6.
12. Mirai, M., Tanaka, K., Shimizu, T. et al. Cepharanthin a multidrug resistant modifier, is a substrate for P-glycoprotein. J Pharmacol Exp Ther 1995, 275: 73-8.
13. Asaumi, J., Kawasaki, S., Nishikawa, K., Kuroda, M., Hraki, Y. Effects of hyperthermia and cepharanthin on adriamycin accumulation with changes in extracellular pH. Int J Hyperthermia 1995, 11: 27-35.
14. Asaumi, J., Nishikawa, K., Matsuoka, H. et al. Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice. Anticancer Res 1995, 15: 67-70.
15. Kawai, K., Sasaki, T., Saijo-Kurita, K., Akaza, H., Koiso, K., Ohno, T. Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay. Cancer Immunol Immunother 1992, 35: 225-9.
16. Cohen, J.J., Duke, R.C. Glucocorticoid activation of a calcium dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol 1984, 132: 38-42.
17. Ferlini, C., Di Cesare, S., Rainaldi, G. et al. A flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques. Cytometry 1996, 24: 106-15.
18. Tagliabue, G., Pifferi, A., Balconi, G., Mascellani, E., Geroni, C., D'Incalci, M., Ubezio, P. Intracellular glutathione heterogeneity in L1210 murine leukemia sublines made resistant to DNA-interacting anti-neoplastic agents. Int J Cancer 1993, 54: 435-42.
19. Bass, D.A., Parce, J.W., Dechatelet, L.R., Szejda P., Seeds, M.C., Thomas, M. Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation. J Immunol 1983, 130: 1910-7.
20. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992, 356: 314-7.
21. Watanabe-Fukunaga, R., Brannan, C.I., Itoh, N. et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992, 148: 1474-9.
22. 2+-dependent endonuclease activity in L1210 cells during apoptosis induced by 1-D arabinofuranosylcytosine: Possible involvement of activating factor(s). Jpn J Cancer Res 1995, 86: 677-84.
23. Hord, J.M., Hait, W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev 1990, 42: 155-99.
24. Roninson, I.B. The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem Pharmacol 1992, 43:95-102.
25. Norris, M.D., Graaf, D.D., Haber, M. et al. Involvement of MDR1 P-glycoprotein in multifactorial resistance to methotrexate. Int J Cancer 1996, 65: 613-9.
26. Ralhan, R., Narayan, M., Salotra, P., Shukla, N.K., Chuhan, S.S. Evaluation of P-glycoprotein expression in human oral oncogenesis: Correlation with clinicopathological features. Int J Cancer 1997, 72: 728-34.
27. Furusawa, S., Fujimura, T., Kawauchi, H., Sasaki, K., Takayanagi, Y. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells. Res Commun Pathol Pharmacol 1991, 71: 321-36.
28. Mankhetkorn, S., Teodori, E., Scapecchi, S., Garnier-Suillerot, A. Study of P-glycoprotein functionality in living resistant K562 cells after photolabeling with a verapamil analogue. Biochem Pharmacol 1996, 52: 213-7.
29. Dantzig, A.H., Shepard, R.L., Cao, J. et al. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res 1996, 56: 4171-9.
30. Fujimura, T., Shibata, H., Mackawa, I. et al. Reversal of resistance to doxorubicin with cepharanthine in murine P388 leukemia cells. Jpn J Pharmacol 1990, 54: 464-7.
31. Kisara, S., Furusawa, S., Murata, R., Hikichi, N., Takayanagi, Y., Sasaki, K. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells. Oncol Res 1995, 3/4: 191-200.
32. Hotz, M.A., Traganos, F., Darzynkiewicz, Z. Change in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerase II inhibitor forstriecin in MOLT-4 and HL60 cells are revealed by altered DNA sensitive to denaturation. Exp Cell Res 1992, 201: 184-91.
33. Bursch, W., Kleine, K., Tenniswood, M. The biochemistry of cell death by apoptosis. Biochem Cell Biol 1990, 68: 1071-4.
34. Higuchi, Y. Antitumor effect of Streptococcus pyogenes by inducing hydrogen peroxide production. Jpn J Cancer Res 1996, 87: 1271-9.
35. Chouaib, S., Robinet, E., Zyad, A., Branellec, D. The tumor necrosis factor a: Pleiotropic cytokine. Bull Cancer 1992, 79: 935-49.
36. Nagata, S., Golstein, P. The Fas death factor. Science 1995, 267: 1449-56.
37. Itoh, N., Yonehara, S., Ishii, A. et al. The polypeptide encoded by the cDNA for human cell-surface antigen Fas can mediate apoptosis. Cell 1991, 66: 233-43.